Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.
Rosario Le MoliPasqualino MalandrinoMarco RussoDario TuminoTommaso PiticchioAdriano NaselliValentina RapicavoliAntonino BelfioreFrancesco FrascaPublished in: Endocrinology, diabetes & metabolism (2023)
L-t4 dose is the most important predictor of GD, BMR modulates T4 levels in obese athyreotic patients that are resistant to L-T4 replacement therapy.